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(NRB, 1), an existing but infrequently used rodenticide, is known to be uniquely toxic to rats but relatively 
harmless to other rodents/mammals. However, as an acute vasoactive, NRB has a rapid onset of action, often 
leading to sub-lethal uptake/bait shyness. Recently, it was brought to our attention that baits containing two 
independently sourced batches of NRB (which differed noticeably in their stereochemical composition) 
displayed markedly different palatability/efficacy profiles in rats. Accordingly, with a view to independently 
evaluating the individual isomers of NRB in rats by means of a palatability and efficacy bait trial, this research 
describes the isolation of the individual isomers of endo-NRB (Y, V, W and U) from the parent mixture, by 
means of a chemical derivatization strategy.  
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Introduction 
 
Discovered in the 1960s, norbormide (NRB, 1) (Figure 1), a vasoactive also marketed under the trade names 
Shoxin® and Raticate,® was found to be uniquely toxic to rats but relatively harmless to other rodents and 
mammals.1,2 NRB is also known to display unique stereo- and species-specific activity both in vitro3,4 and in 
vivo;5 the mechanisms behind these effects have yet to be fully clarified.6,7 Disappointingly, to date, efforts to 
establish NRB as a viable rodenticide have been largely unsuccessful. Over time, rats have developed an 
evolutionary trait relating to how they sample food, particularly novel food; this survival strategy is most likely 
linked to their lack of an emetic centre, and thus their incapacity, as a species, to vomit. As an acute poison, 
NRB has a rapid onset of action in rats with toxic symptoms being registered within minutes of ingestion, and 
available evidence suggests that rats can develop a learnt aversion to this poison following the consumption of 
a sub-lethal dose during sampling, a phenomenon referred to as bait-shyness.8,9 NRB is also known to be 
relatively unpalatable to rats.10-12 Although efforts to address this palatability problem using 
microencapsulation technologies have had varying degrees of success, the onset of symptoms has yet to be 
sufficiently delayed to significantly improve palatability,13,14 and the potential for sub-lethal dosing remains a 
major hurdle. More recently, a prodrug approach15-17 revealed a series of NRB derivatives which were 
demonstrated to be more palatable/efficacious to rats.  
Recently, it was brought to our attention18 that baits (of the same formulation) containing two 
independently sourced batches of NRB (herein termed NRB#A and NRB#B) displayed markedly different 
palatability/efficacy profiles in rats; as demonstrated using a two-choice bait trail, where each rat was offered 
both poisoned and non-poisoned food (Table 1). Upon closer inspection, NRB batches #A and #B were both 
demonstrated to be of high purity, but differed noticeably in their stereochemical composition (Figure 1 and 
Table 2); NRB exists as a mixture of up to eight stereoisomers.4 NRB#A was revealed to contain elevated levels 
of isomers V (NRB V, 1V) and, to a lesser extent, U (NRB U, 1U); relative to NRB#B. Given that consumption 
levels were demonstrated to be lower for bait containing NRB#A, it was tentatively postulated that the 
increased presence of NRB V may, at least in part, be accountable for such an observation; NRB V is known to 
be the most toxic NRB isomer to rats (Table 2).5 With a view to independently evaluating the individual 
isomers of NRB in rats by means of a palatability and efficacy bait trial, this research describes the isolation of 
the individual isomers of NRB (Y, V, W and U) from the parent mixture by means of a chemical derivatization 
strategy. 
 
Table 1. Two-choice bait-palatability and efficacy trial observations for NRB batches #A and #B, in Sprague-
Dawley rats (see Figure 1 and Table 2) 
Norbormide 
batch 
Mean bait consumption 
(g) (as a % of body mass 
±SE)a 
Mean NRB dose 
consumed ±SE (and 
range) (mg/kg) 
Mean NRB dose consumed 
that led to death ±SE (and 
range) (mg/kg) 
Mortalityb 
#A 1.35 (0.39±0.05) 39±5 (17-70) 44±7 (29-61) 5/12 
#B 1.89 (0.55±0.06) 55±6 (35-110) 56±6 (35-110) 11/12 
a Rats were presented with a choice of standard lab pellets (20 g) and a bait formulation containing 1% w/w 
toxicant (20 g) for 2 days, following 3 days ‘pre-feeding’ with a choice of standard lab pellets and a bait 
formulation free of toxicant (n = 12, 6 male rats and 6 female rats). b Total number of rat deaths recorded/total 
number of rats participating in the experiment. 
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Figure 1. Naming and numbering of the individual stereoisomers of NRB (1).4 
 
Table 2. Stereoisomeric composition of NRB batches #A and #B, and individual NRB isomer toxicity in rats (see 
Figure 1)5 
 Stereoisomeric composition (%)a 
Norbormide batch Y V W U R T X S 
#A 36 32 16 13 0 0 3 0 
#B 45 22 23 10 0 0 0 0 
LD50 (rat, i.v.) mg/kg 0.50 0.15 5.0 1.5 >10 >8.5 >10 >8.0 
LD50 (rat, p.o.) mg/kg <5 2.1 n/a n/a n/a n/a >100 n/a 
a As determined by achiral RP-HPLC analysis (AUC, λ254 nm), in correlation with 1H NMR.4 n/a = Not available. 
 
 
Results and Discussion 
 
Chemical synthesis. Original research conducted by Mohrbacher and Poos over fifty years ago successfully 
accomplished NRB isomer separation using an exhaustive mixture of fractional recrystallization and 
preparative TLC methods.19 Recoveries were reported to be extremely low (<0.01% yield), generating mere 
milligram quantities of the isolated NRB isomers from kilograms of mixed NRB; yet sufficient material was 
obtained to allow for the individual NRB isomers to be evaluated for toxicity in rats by i.v., and in some cases, 
p.o. (Table 2).5 Accordingly, in-house efforts to achieve a chromatographic separation of NRB using modern-
day techniques were undertaken, but with only limited success. Using normal phase flash chromatography 
methods it was not possible to attain a clean separation of all the isomers, regardless of stationary phase or 
eluent.  
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In parallel, work continued on developing a strategy which would ultimately enable the isolation of the 
individual isomers of NRB, on a scale sufficient for extended in vivo biological evaluation. Previous studies 
working with NRB derivatives16,17 had revealed that chromatographic differentiation between the isomers 
could be achieved through the installation of a group on the N-dicarboximide nitrogen. Employing a chemical 
derivatization strategy largely built on established literature protecting group chemistry, a selection of novel 
N-dicarboximide derivatives of NRB were synthesized in an effort to induce greater differentiation between 
the isomers during chromatographic separation. Requirements for such a strategy fell into three main 
categories: 1) derivatization must be clean, and the resulting derivative be of sufficient stability to allow for its 
isolation; 2) a clear chromatographic separation must be attained to reveal all four major isomers present in 
mixed NRB (NRB Y, V, W, U); and 3) the derivatizing group must be removable under conditions to which NRB 
is stable. Given that NRB’s tolerance to various cleavage environments was unknown, a broad range of 
derivatizing groups were considered.  
Using Kocienski’s classification of protecting groups,20 N-dicarboximide derivatives 2-28 were split into 10 
distinct groups based on the primary method of cleavage used for their removal (Table 3). Acid-labile (both 
Brønsted and Lewis acid) derivatives 2 (R = Tr), 11 (R = EOM), 15 (R = Boc) and 24 (R = Ts) were considered as 
exemplars within this particular category. Base sensitive examples included derivatives 3 (R = Ac), 4 (R = TFA), 
5 (R = Bz) and 14 (R = Boz). Derivatives 6 (R = Bn), 7 (R = NAP), 12 (R = BOM) and 16 (R = Cbz) where primarily 
prepared with a view to removing the derivatizing group using hydrogen in the presence of a transition metal 
catalyst such as palladium(0); under mild hydrogenolysis conditions it was presumed that the tri- and tetra-
substituted olefin bonds of NRBs would be stable to such reducing environments. Conversely, following an 
oxidation approach, PMB and DMB groups are known to undergo single electron transfer in the presence of 
certain oxidants, for example ammonium cerium(IV) nitrate (CAN) or 2,3-dichloro-5,6-dicyano-p-
benzoquinone (DDQ); which was to be probed using derivatives 8 (R = PMB) and 9 (R = DMB). Transition metal 
catalysis was to be employed in the cleavage of derivatives 10 (R = All) and 17 (R = Aloc), using palladium(0) 
catalysts to afford π-allyl palladium complexes which could then be trapped by mild nucleophiles such as 
dimedone or morpholine. Two distinct families of derivatizing groups cleaved by fluoride ions (fluoride-
induced fragmentation) were also explored; those where the silyl group was directly attached to the N-
dicarboximide, for example derivatives 21 (R = TBDMS), 22 (R = TBDPS) and 23 (R = TIPS), and those which 
proceeded via a β-elimination mechanism, such as derivatives 13 (R = SEM) and 18 (R = Teoc). Reductive 
elimination (also following a β-elimination pathway) was to be explored using zinc-acetic acid (Zn/AcOH) in the 
cleavage of 2,2,2-trichloroethyl derivatives such as derivative 19 (R = Troc). Furthermore, alternative cleavage 
techniques may be employed other than the primary methods outlined above; for example derivatives 6 (R = 
Bn), 7 (R = NAP), 16 (R = Cbz) and 24 (R = Ts) are all known to cleave under dissolving metal reduction 
conditions, such as sodium in liquid ammonia (Na/NH3) or lithium di-tert-butylbiphenyl (LiDBB). Mild-base 
catalyzed removal of the 9-fluorenylmethoxycarbonyl group, such as that found in derivative 20 (R = Fmoc), 
provided a further example of a β-elimination-type approach. Finally, nosyl, and more recently tosylvinyl, 
groups are known to cleave under mild conditions employing thiols (e.g. PhSH) in combination with bases such 
as DIPEA, providing examples 25 (R = 2-Ns), 26 (R = 4-Ns), 27 (R = E-Tsv) and 28 (R = Z-Tsv).  
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Table 3. Common methods for the removal of protecting groups used in this study 
Methoda Reagent examples Protecting groups 
Acid HCl, TFA, AlCl3 Tr, EOM, Boc, Ts 
Basic solvolysis K2CO3, NaOH Ac, TFA, Bz, Boz 
Hydrogenolysis  Pd/C, Pd(OH)2/C Bn, NAP, BOM, Cbz 
Oxidation CAN, DDQ PMB, DMB  
Transition metal catalysis Pd0/dimedone All, Aloc 
Fluoride ions TBAF TBDMS, TBDPS, TIPS, SEM, Teoc 
Reductive elimination Zn/AcOH Troc 
Dissolving metal reduction Na/NH3, LiDBB Bn, NAP, Cbz, Ts 
β-Elimination piperidine Fmoc 
Other  PhSH/DIPEA Ns, Tsv 



























endo-29 R = CH2OH
endo-1   R = H (89%)DHM  
 
Scheme 1. General conditions. Derivatization (in conjunction with Table 4): TrCl, Et3N, DCM, rt, 24 h (to give 2); 
Ac2O, Et3N, DMAP, DCM, rt, 24 h (3); TFAA, Et3N, DCM, rt, 24 h (4); BzCl, Et3N, DCM, rt, 24 h (5); BnCl, K2CO3, 
DMF, rt, 16 h (6); NAPBr, K2CO3, DMF, rt, 16 h (7); PMBCl, K2CO3, DMF, rt, 16 h (8); DMBCl, K2CO3, DMF, rt, 16 h 
(9); AllBr, K2CO3, TBAI, DMF, rt, 16 h (10); EOMCl, NaH, DMF, rt, 3 h (11); BOMCl, Et3N, DCM, rt, 24 h (12); 
SEMCl, NaH, DMF, rt, 3 h (13); BozCl, K2CO3, DMF, rt, 16 h (14); Boc2O, DMAP, DCM, rt, 16 h (15); CbzCl, K2CO3, 
THF, rt, 16 h (16); AlocOSu, NaH, DMF, rt, 3 h (17); TeocONp, Et3N, DCM, rt, 24 h (18); TrocCl, Et3N, DMF, rt, 16 
h (19); FmocOSu, NaH, THF, rt, 3 h (20); TBDMSCl, NaH, DMF, rt, 16 h (21); TBDPSCl, NaH, DMF, rt, 3 h (22); 
TIPSCl, NaH, DMF, rt, 3 h (23); TsCl, Et3N, DCM, rt, 24 h (24); 2-NsCl, Et3N, DCM, rt, 24 h (25); 4-NsCl, Et3N, 
DCM, rt, 24 h (26); tosylacetylene, DMAP, MeCN, 50 °C, 20 h (27); tosylacetylene, Et3N, MeCN, 0°C to rt, 0.5 h 
(28).  
 
Cleavage (in conjunction with Table 5): H2, Pd/C, aq. HCl (conc.), MeOH, 3 atm., 40 °C, 18 h; H2, Pd(OH)2/C, 
aq. HCl (conc.), MeOH, 3 atm., 40 °C, 18 h (Method A); H2, Pd(OH)2/C, AcOH, MeOH, 1 atm., rt, 18 h (Method 
B); Na/NH3, THF, -60 °C, 2 h; LiDBB, THF, -78 °C, 2 h; CAN, MeCN, H2O, rt, 18 h; DDQ, DCM, H2O, 70 °C, 18 h; 4 
M HCl/1,4-dioxane, MeOH, 70 °C, 18 h; TFA, 60 °C, 18 h; AlCl3, PhMe, 80 °C, 18 h; TBAF, THF, 60 °C, 4 h; K2CO3, 
MeOH, rt, 18 h. Dehydroxymethylation (DHM): i) Et2NH, DCM, rt, 1 h, ii) NaBH(OAc)3, AcOH, rt, 1 h (1).  
 
The synthesis of derivatives 2, 5-17, 20, 23, 24, 27 and 28 (starting from NRB#A), proceeded smoothly 
using standard literature methods; conversely, no product formation was observed in the preparation of 
compounds 18 and 25, whereas derivatives 3, 4, 19, 21, 22 and 26 were all found to be of insufficient stability 
and/or contained inseparable side-products (Scheme 1, Table 4). Disappointingly, on attempting 
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chromatographic separation, derivatives 2, 5, 9-11, 15-17, 20, 23, 24, 27 and 28 failed to clearly reveal all 4 
major isomers present within the parent NRB#A mixture, and as a consequence these particular derivatives 
were abandoned. Of the derivatives which were found to separate (6-8 and 12-14) (Scheme 1, Tables 4 and 5), 
initial efforts to cleave benzyl derivative 6 using hydrogenolysis (both Pd/C and Pd(OH)2/C) proved 
unsuccessful, even at elevated temperature and pressure (all cleavage experiments were conducted on the 
purified stereoisomeric mixture, unless stated otherwise). Similarly, 2-naphthylmethyl derivative 7, prepared 
as a further example of a benzyl-type protecting group with known enhanced lability towards palladium(0)-
catalyzed hydrogenolysis,21 was also revealed to be stable. As an alternative method of cleavage, attempts 
were next made to un-derivatize compounds 6 and 7 via a dissolving metal reduction approach. 
Disappointingly, reactions using Na/NH3 led to a complex mixture of products, as was also found to be the 
case using LiDBB. 
 
Table 4. Norbormide N-dicarboximide derivatization and chromatographic separation (in conjunction with 
Scheme 1)   
Compound  R Yield (%)a Separation Entry Compound R Yield (%)a Separation 
2 Tr 18 No 15 16 Cbz 95 No 
3 Ac -b - 16 17 Aloc 36 No 
4 TFA -b - 17 18 Teoc -c - 
5 Bz 14 No 18 19 Troc -b - 
6 Bn 87 Yes 19 20 Fmoc 30 No 
7 NAP 96 Yes 20 21 TBDMS -b - 
8 PMB 57 Yes 21 22 TBDPS -b - 
9 DMB 72 No 22 23 TIPS 92 No 
10 All 77 No 23 24 Ts 49 No 
11 EOM 59 No 24 25 2-Ns -c - 
12 BOM 78 Yes 25 26 4-Ns -d - 
13 SEM 75 Yes 26 27 E-Tsv 80 No 
14 Boz  98 Yes 27 28 Z-Tsv 83 No 
15 Boc 99 No      
Derivatization group (R) abbreviations, according to Kocienski20: Ac = acetyl; All = allyl; Aloc = 
allyloxycarbonyl; Bn = benzyl; Boc = tert-butyloxycarbonyl; BOM = benzyloxymethyl; Boz = 
benzoyloxymethyl; Bz = benzoyl; Cbz = benzyloxycarbonyl; DMB = 3,4-dimethoxybenzyl; EOM = 
ethoxymethyl; Fmoc = 9-fluorenylmethoxycarbonyl; NAP = 2-naphthylmethyl; 2-Ns = 2-nosyl; 4-Ns = 
4-nosyl; PMB = 4-methoxybenzyl; SEM = 2-(trimethylsilyl)ethoxymethyl; TBDMS = tert-
butyldimethylsilyl; TBDPS = tert-butyldiphenylsilyl; Teoc = 2-(trimethylsilyl)ethoxycarbonyl; TFA = 
trifluoroacetyl; TIPS = triisopropylsilyl; Troc = 2,2,2-trichloroethoxycarbonyl; Tr = trityl; Ts = tosyl; Tsv 
= 2-(4-tosyl)vinyl. a Sum of all isomers. b Product was found to be unstable. c Reaction failed. d 
Inseparable side-products formed. 
 
Moving our focus onto derivatizing groups designed to cleave under oxidative conditions, PMB derivative 8 
was subsequently revealed to be stable in the presence of both CAN and DDQ; on the strength that both 
benzyl and 2-naphthylmethyl ethers are known to be more resistant to oxidative cleavage than their PMB 
counterparts, efforts to deprotect derivatives 6 and 7 under oxidative conditions were not pursued.20,22 On a 
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related note, while PMB ethers have been reported to undergo hydrogenolysis, given that benzyl ethers are 
known to cleave more readily in the presence of H2-Pd/C,20 and with the knowledge that derivative 6 had 
proven stable to such conditions, this experiment was similarly discounted. Likewise, since PMB ethers are 
recognized as being more stable to dissolving metal reductions than benzyl ethers,23 the deprotection of 
derivative 8 using such methods was not attempted. Instead, efforts to remove the PMB group of derivative 8 
using Brønsted acids were investigated. Again, disappointingly, derivative 8 failed to cleave in the presence of 
neat trifluoroacetic acid (TFA), even at elevated temperature, while treatment with aqueous hydrochloric acid 
(HCl) led only to decomposition products. Lewis acid (aluminium chloride (AlCl3)) methods also failed to 
deprotect derivative 8. Knowing that PMB ethers are generally less stable to acid than their unsubstituted 
benzyl counterparts, attempts to cleave derivatives 6 and 7 using either Brønsted or Lewis acids were not 
attempted.20  
 
Table 5. Norbormide N-dicarboximide derivative cleavage method/reagent (in conjunction with Scheme 1)   
Cleavage method Reagent R (Compounds)  Observations Yield (%)a 
Hydrogenolysis H2, Pd/C; Pd(OH)2/C (A) Bn (6), NAP (7) Starting material recovered - 
 H2, Pd(OH)2/C (B) BOM (12) Gave compound 29 75 
Dissolving metal 
reduction 
Na/NH3; LiDBB Bn (6), NAP (7) Inseparable side-products 
formed 
- 
Oxidation CAN; DDQ  PMB (8) Inseparable side-products 
formed 
- 
Acid HCl PMB (8) Inseparable side-products 
formed 
- 
 TFA; AlCl3  PMB (8) Starting material recovered - 
 TFA BOM (12) Gave compound 29 76 
 HCl SEM (13) Gave compound 29 82 
 HCl Boz (14) Gave compound 29 91 
Fluoride TBAF SEM (13) Starting material recovered - 
Basic solvolysis K2CO3 Boz (14) Gave compound 29 73 
a Sum of all isomers; cleavage method and conditions initially trialled on unseparated mixture. 
 
As a further example of a derivatizing group which permitted the required chromatographic separation of 
isomers, BOM derivative 12 was now subjected to an array of cleavage conditions. Initial approaches focused 
on catalytic hydrogenolysis, using H2-Pd(OH)2/C in the presence of dilute aqueous acid. Contrary to 
expectation, NRB was not revealed as the product of the hydrogenolysis, instead the reaction was found to 
terminate at N-hydroxymethyl NRB derivative 29 (in 75% yield); it was originally anticipated that intermediate 
29 would be unstable and spontaneously collapse in situ to furnish NRB. The benzyl group of BOM derivative 
12 could similarly be removed under heating in TFA, again leading to N-hydroxymethyl NRB 29 (76% yield). 
Analogous observations were noted in the cleavage of SEM derivative 13 using HCl (only starting materials 
were recovered using tetra-n-butylammonium fluoride (TBAF)), and in the deprotection of Boz derivative 14 
using either aqueous acid (HCl) or base (potassium carbonate (K2CO3)), in all instances affording N-
hydroxymethyl NRB 29 (82%, 91% and 73% yield, respectively).  
It has been reported that N-hydroxymethyl dicarboximides can be hydrolyzed under basic conditions to 
furnish the corresponding unsubstituted dicarboximides.24-29 Ensuing attempts to hydrolyze N-hydroxymethyl 
Arkivoc 2021, x, 40-53   Jay-Smith, M. et al. 
 
 Page 47  ©AUTHOR(S) 
NRB 29 using ammonium hydroxide (NH4OH)25-27 led only to dicarboximide ring-opened side-products. In an 
effort to limit such unwanted hydrolysis, a selection of tertiary amine bases were screened (to be used under 
non-aqueous conditions).28,29 Reactions employing either N-methylmorpholine (NMM), 1,4-
diazabicyclo[2.2.2]octane (DABCO), triethylamine (TEA) or N,N-diisopropylethylamine (DIPEA) (in order of 
increasing base strength) resulted in only the partial conversion of N-hydroxymethyl NRB 29 to NRB (12%, 9%, 
16%, 81%, respectively, rt, 24 h; according to achiral RP-HPLC of the reaction mixture). Conversely, the 
reaction proceeded to completion within 15 minutes in the presence of strongly basic, non-nucleophilic 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) (pKa 12).30 Unexpectedly, upon isolation (standard aqueous work-up, pH 
6.5) of the product, despite the reaction having apparently proceeded to >99% completion (according to 
achiral RP-HPLC), an inseparable mixture of NRB and N-hydroxymethyl NRB 29 was observed (ca. 3:1, 
respectively). It is tentatively postulated that an equilibrium is in existence between N-hydroxymethyl NRB 29 
and the corresponding reaction breakdown products, NRB and formaldehyde (thus allowing the reaction to 
proceed in the reverse direction during work-up) (Figure 2). Similar observations have been reported for 




Figure 2. Postulated equilibrium between N-hydroxymethyl NRB derivative 29 and NRB (1) in the presence of 
formaldehyde (scavenged by means of in situ reductive amination).  
 
On the premise that the formaldehyde generated in the reaction was indeed responsible for the N-
hydroxymethylation of NRB during product isolation, attempts were made to sequester it from the reaction 
mixture using various ‘scavenging’ techniques. A number of reagents have been shown to selectively react 
with formaldehyde, including sodium bisulfite,31 tris(hydroxymethyl)aminomethane (Tris),32 semicarbazide33 
and urea.34 Alternatively, the selective reduction of aldehydes in the presence of other carbonyl-containing 
functional groups has been achieved using sodium triacetoxyborohydride (NaBH(OAc)3).35 Subsequent 
attempts to induce the breakdown of N-hydroxymethyl NRB 29 in the presence of Tris failed, likely owing to its 
lower basicity (pKa 8.5).36 On repeating the reaction in the presence of both Tris (as a formaldehyde scavenger) 
and DBU (to promote N-dehydroxymethylation), again, a mixture of NRB and N-hydroxymethyl NRB 29 was 
observed post work-up. Instead, in an effort to scavenge formaldehyde by means of hydride reduction, a 
sequential one-pot two-step process commencing with DBU-induced N-dehydroxymethylation, followed by 
the addition of NaBH(OAc)3/AcOH in an attempt to consume the formaldehyde by-product, again led to a 
mixture of NRB and N-hydroxymethyl NRB 29. Replacing NaBH(OAc)3 with the more powerful hydride source, 
sodium borohydride (NaBH4), led to partial reduction of the dicarboximide ring. On a related note, NaBH(OAc)3 
has been demonstrated to act as a mild hydride reductant in the reductive amination of both aldehydes and 
ketones.37,38 Correspondingly, it was proposed that substituting DBU (a tertiary amine) with a strongly basic 
secondary amine, for example diethylamine (pKa 10.5),39 with a view to generating an iminium ion which in 
turn could then undergo mild selective reduction in situ (using NaBH(OAc)3), could offer an alternative way of 
preventing the reformation of N-hydroxymethyl NRB 29 post cleavage (Figure 2). To our immense 
Arkivoc 2021, x, 40-53   Jay-Smith, M. et al. 
 
 Page 48  ©AUTHOR(S) 
gratification, using this procedure, NRB was afforded quantitatively upon work-up (and in 89% yield after 
purification) (Scheme 1); note, using diethylamine in the absence of NaBH(OAc)3 again resulted in a mixture of 
NRB and N-hydroxymethyl NRB 29 post work-up.   
 
Table 6. Isolated isomer recovery from NRB#A using a chemical derivatization strategy (via Boz-protected 
derivative 14; following method B) (see Figure 1)  
% Isomer Recoverya 
NRB Yb NRB V NRB W NRB Uc 
64d 49d 66d 65d 
a % recovery based on the maximum theoretical yield (100%) of each isomer 
available within the parent NRB#A mixture (1.3 g scale). b Contains ≤5% isomer U. 
c Contains ≤3% isomer W. d Combined yield over 3 stages: derivatization, 
chromatographic separation, cleavage (using aqueous HCl method).  
 
With a successful chemical derivatization/cleavage strategy now unveiled, we next set out to obtain 
sufficient quantities of each NRB stereoisomer to supply the intended palatability and efficacy bait trial. Basing 
selection on a combination of the fundamental requirements involved in the derivatization strategy (ease of 
derivatization, chromatographic separation and cleavage), an approach proceeding via Boz derivative 14 was 
nominated as the best available route (Scheme 1, Tables 4 and 5). Starting from mixed NRB, sequential 
derivatization and chromatographic separation afforded the isolated individual isomers of Boz derivative 14 in 
high recovery: 14Y (92%, based on the maximum theoretical yield of each isomer available within the parent 
NRB#A mixture),  14V (85%), 14W (94%) and 14U (92%). Subsequent deprotection (HCl), via N-hydroxymethyl 
NRB 29 (not isolated), which in turn was N-dehydroxymethylated using diethylamine in combination with 
NaBH(OAc)3/AcOH, successfully furnished NRB Y, V, W and U. Dependably, overall isomer recovery ranged 
between 49-66%, emphatically surpassing previous literature isolation methods employing fractional 
recrystallization and preparative TLC techniques (<0.01% yield) (Table 6).19  
 
Scanning electron microscopy (SEM). SEM analysis of the isolated individual NRB isomers (NRB Y, V, W and U) 
revealed a high degree of similarity among the samples (being largely comprised of widely polydisperse 
particle sizes exhibiting similar crystalline morphology; minor surface-scale deviations were observable at 
4000× magnification) (Figure 3).  
 
Biological evaluation: bait palatability and efficacy trial in rats. Having now successfully isolated the 
individual endo-isomers of NRB using the aforementioned chemical derivatization strategy in sufficient 
quantity to undergo palatability and efficacy evaluation in rats, NRB Y, V, W and U were now assessed in a bait 
trial; for completeness, an exclusively exo-NRB mixture (NRB R/S/T/X)40 was appraised in parallel to determine 
what effect, if any, the non-lethal (to rats) isomers of NRB have on palatability.5 Following 1 day ‘pre-baiting’ 
with a highly palatable bait formulation free of toxicant, rats (Sprague-Dawley) were fed bait containing either 
NRB Y, V, W, U or R/S/T/X, at a concentration of either 0.3% or 0.1 w/w (Table 7); NRB#B was employed as a 
positive control. Upon exchanging the non-toxic ‘pre-feed’ bait for bait containing either NRB Y (0.63±0.16, as 
a % of body mass), NRB V (0.77±0.18) or NRB U (0.86±0.09), consumption was found to be largely comparable 
across the different isomers; and similar to that of the NRB control bait (NRB#B 0.90±0.20). Conversely, baits 
containing either NRB W (1.50±0.24) or NRB R/S/T/X (1.59±0.01) were revealed to be consumed in 
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significantly greater quantities. With respect to mortality, baits containing either NRB Y (3 death recorded 
from a total of 4 rats) or NRB V (2/3) displayed a level of efficacy similar to that of the NRB control (NRB#B 
3/3), whereas baits containing NRB W (0/3), NRB U (0/3) or NRB R/S/T/X (0/3) were all demonstrated to be 
non-lethal (in the quantities consumed). Given that NRB isomers W, U, R, S, T and X have all previously been 
demonstrated to be of relatively lower toxicity to rats (when compared directly to isomers V and Y),5 such an 
observation was not entirely unexpected. Note, earlier studies working with baits containing 0.1% w/w 
toxicant (chosen on the basis of best minimizing the impact of mortality on the ensuing palatability data by 
working with lower % loadings of the toxicant) failed to allow for differentiation between the toxic baits, since 




Figure 3. Scanning electron micrographs of NRB V, Y, U and W; at 1000× and 4000× magnification. 
 
Table 7. No-choice bait-palatability and efficacy trial observations for isolated NRB isomers Y, V, W, U and 
R/S/T/X, alongside NRB#B (as a control), in Sprague-Dawley rats (see Figure 1) 





Mean bait consumption as a 
% of body mass ±SE 
Mean NRB dose 
consumed ±SE (mg/kg) Mortalityc 
Y 1.66  0.63±0.16  19± 6  3/4 
V 2.12  0.77±0.18 23±5  2/3  
W 4.42  1.50±0.24  45±7  0/3  
U 2.73  0.86±0.09  26±3 0/3  
R/S/T/Xd 5.00  1.59±0.01  48±1  0/2  
NRB#B 2.72 0.90±0.20 27±6 3/3 
a Rats were presented with the toxicant in a highly palatable bait formulation (5 g, 0.3% w/w toxicant) 
following 1 day ‘pre-feeding’ with a highly palatable bait formulation free of toxicant (starting with n = 5 for 
each test compound; rats which unequivocally refused to consume the ‘pre-feed’ bait were subsequently 
removed from the trial). b Over 2 h. c Total number of rat deaths recorded/total number of rats participating 
in the experiment. d R/S/T/X, 26:14:14:46 ratio.  
 
U (1000x) W (1000x) V (1000x) Y (1000x) 
U (4000x) W (4000x) V (4000x) Y (4000x) 
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Conclusions 
 
Each of the endo stereoisomers of NRB (Y, V, W and U) was successfully isolated using a novel chemical 
derivatization strategy (using methods accessible to those skilled-in-the-art, and without the need for 
expensive apparatus). Succinctly, through the reversible introduction of a Boz-substituent onto the N-
dicarboximide nitrogen of NRB, chromatographic differentiation between the stereoisomers could be 
achieved. Subsequent cleavage of the separated NRB Boz-isomers (compound 14), using a two-step one-pot 
reaction procedure (via N-hydroxymethyl NRB 29), revealed NRB Y, V, W and U in good yield. Disappointingly, 
given the privileged pharmacological tools available as a product of this research, no clear relationship 





General.  All reagents were used as supplied, unless stated otherwise. Solvents were purified using standard 
methods. Analytical thin layer chromatography (TLC) was carried out on pre-coated silica gel plates 
(Merck/UV254) and products were visualized by UV fluorescence. Flash chromatography was performed using 
silica gel (Riedel-de Haën, particle size 0.032–0.063 mm). Distillation of cyclopentadiene was carried out using 
a Vigreux apparatus.  
 
5-(α-Hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)-5-norbornene-2,3-dicarboximide (1Y).4 To a 
solution of 14Y (159 mg, 0.25 mmol) in MeOH (3 mL) was added a solution of HCl in 1,4-dioxane (3 mL, 4 M), 
and the mixture stirred at 70 °C for 18 h. The solvent was then removed in vacuo and the resulting residue 
taken up in DCM, washed with aq. NaH2PO4/Na2HPO4 (0.5 M, pH 6.6), dried over anhydrous MgSO4, filtered 
and the filtrate concentrated in vacuo. The resulting residue was then taken up in a solution of Et2NH (25 μl, 
0.25 mmol) in DCM (3 mL), and stirred at r.t. for 1 h. NaBH(OAc)3 (52 mg, 0.25 mmol) and AcOH (15 μl, 0.25 
mmol) were then added and the mixture stirred at r.t. for a further 1 h. The mixture was then diluted with aq. 
NaH2PO4/Na2HPO4 (0.5 M, pH 6.6; to achieve a soln. pH of 6.6) and extracted with DCM. The combined organic 
extracts were then dried over anhydrous MgSO4, filtered and the filtrate concentrated in vacuo. Purification by 
column chromatography (petroleum ether/AcOEt, 1:1) afforded 1Y (88 mg, 70%) as a white solid (for spectral 
data, see supporting information).   
5-(α-Hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)-5-norbornene-2,3-dicarboximide (1V).4  A similar 
procedure to that previously described for the preparation of 1Y was followed using 14V (345 mg, 0.53 mmol) 
and HCl (5 mL, 4 M in 1,4-dioxane) in MeOH (5 mL), followed by Et2NH (53 μl, 0.53 mmol) in DCM (2 mL), then 
NaBH(OAc)3 (113 mg, 0.53 mmol) and AcOH (30 μl, 0.53 mmol). Purification by column chromatography 
(petroleum ether/AcOEt, 1:2) afforded 1V (160 mg, 58%) as a white solid (for spectral data, see supporting 
information). 
5-(α-Hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)-5-norbornene-2,3-dicarboximide (1W).4 A 
similar procedure to that previously described for the preparation of 1Y was followed using 14W (84 mg, 0.13 
mmol) and HCl (2 mL, 4 M in 1,4-dioxane) in MeOH (2 mL), followed by Et2NH (13 μl, 0.13 mmol) in DCM (1 
mL), then NaBH(OAc)3 (28 mg, 0.13 mmol) and AcOH (7 μl, 0.13 mmol). Purification by column 
chromatography (petroleum ether/AcOEt, 1:1) afforded 1W (47 mg, 70%) as a white solid (for spectral data, 
see supporting information). 
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5-(α-Hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)-5-norbornene-2,3-dicarboximide (1U).4 A similar 
procedure to that previously described for the preparation of 1Y was followed using 14U (95 mg, 0.15 mmol) 
and HCl (2 mL, 4 M in 1,4-dioxane) in MeOH (2 mL), followed by Et2NH (15 μl, 0.15 mmol) in DCM (1 mL), then 
NaBH(OAc)3 (31 mg, 0.15 mmol) and AcOH (9 μl, 0.15 mmol). Purification by column chromatography 
(petroleum ether/AcOEt, 1:1) afforded 1U (53 mg, 71%) as a white solid (for spectral data, see supporting 
information). 
N-(Benzoyloxymethyl)-5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)-5-norbornene-2,3-
dicarboximide (14Y, 14V, 14W, 14U).15 To a solution of NRB#A (1.30 g, 2.54 mmol) and K2CO3 (0.53 g, 3.81 
mmol) in DMF (5 mL) was added chloromethyl benzoate15 (0.51 g, 3.05 mmol), and the mixture stirred at r.t. 
for 16 h. The mixture was then diluted with AcOEt, washed with brine, dried over anhydrous MgSO4, filtered 
and the filtrate concentrated in vacuo. Purification by column chromatography (petroleum ether/AcOEt, 2:1) 
afforded (post separation) 14Y (540 mg, 92%), 14V (445 mg, 85%), 14W (246 mg, 94%) and 14U (197 mg, 92%) 
(% recovery based on maximum theoretical yield of each isomer available within the parent NRB#A mixture), 
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